Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

157
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
157
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

344
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
344
Biostatistics: Overview01:20

Biostatistics: Overview

325
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
325
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

617
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
617
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

725
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
725

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endo-epicardial strategy in persistent and longstanding persistent atrial fibrillation: Clinical outcomes in terms of atrial fibrillation recurrences and burden during continuous monitoring.

Kardiologia polska·2026
Same author

Outcome After Surgery for Type A Intramural Hematoma.

Journal of cardiovascular development and disease·2026
Same authorSame journal

Methods for Wearable-Derived Pulse Rate Measures and Their Application to Modeling the Relationship between Pulse Rate and Motor Activity in Narcolepsy Type 1.

Digital biomarkers·2026
Same author

Methods for analytical validation of novel digital clinical measures: A simulation study.

PloS one·2026
Same author

Functional Regression Methods for Estimating 24-Hour Ambulatory Blood Pressure and Heart Rate Parameters in Narcolepsy Type 1.

Digital biomarkers·2026
Same author

Digital endpoints in clinical trials: building the business case for systematic adoption.

Nature reviews. Drug discovery·2026

Related Experiment Video

Updated: Aug 19, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K

Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials.

Bohdana Ratitch1, Isaac R Rodriguez-Chavez2, Abhishek Dabral3

  • 1Statistics and Data Insights, Bayer, Westmount, Québec, Canada.

Digital Biomarkers
|December 5, 2022
PubMed
Summary

Biometric monitoring technologies offer holistic health insights outside clinics. Statisticians and data scientists face new challenges in validating these digital clinical measures for regulatory approval.

Keywords:
Biometric monitoring technologiesClinical trialsClinical validationDigital healthDigital medicineStatistics

More Related Videos

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

1.4K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.6K

Related Experiment Videos

Last Updated: Aug 19, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

1.4K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.6K

Area of Science:

  • Biomedical Engineering
  • Clinical Data Science
  • Regulatory Science

Background:

  • Biometric monitoring technologies are maturing, enabling holistic health status measurement.
  • These technologies capture daily living data more granularly and objectively than traditional clinical tools.
  • This facilitates health monitoring outside conventional clinical settings.

Purpose of the Study:

  • To discuss key considerations for generating clinical validity evidence for novel clinical measures.
  • To examine the role of statisticians and data scientists in trials using digital clinical measures.
  • To highlight challenges in using biometric monitoring data in clinical trials.

Main Methods:

  • The paper reviews evidence generation strategies for clinical validity.
  • It considers the type and intended use of clinical measures.
  • Regulatory pathways for clinical validity evidence are briefly discussed.

Main Results:

  • Statisticians and data scientists are increasingly involved in trials with digital clinical measures.
  • Analysis objectives for clinical validity differ from traditional safety and efficacy endpoints.
  • Investigators face challenges with data from biometric monitoring technologies.

Conclusions:

  • Generating evidence for clinical validity requires careful consideration of measure type and use.
  • Understanding regulatory pathways is crucial for novel clinical measures.
  • Addressing data challenges from biometric monitoring is essential for successful trials.